Nanalyze January 6, 2025

The mythical “cure for cancer” is often misunderstood. It’s not one wonder drug for the more than 200 types of cancer out there. Each person’s cancer is unique and accompanied by a distinct genetic fingerprint that can be targeted using personalized medicine. These often take the form of expensive cancer drugs, and investing in these drug developers means exposure to lots of external risk factors that can’t be controlled which create lots of volatility. As risk averse investors, we want to reduce volatility.

Perhaps the easiest cure for cancer is simply early detection. Take breast cancer, for instance. A study on early detection showed that “personal cure is achieved for the great majority” when cancer is detected in the...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Provider
Inside A ComForCare Franchise’s Play To Blend Home Care, Senior Living
Healthcare, medtech industries brace for tariffs
Is outpatient cardiology at a tipping point?
The 3 most promising uses for GenAI in healthcare
States with the most, least RNs

Share This Article